| Maria Petrova Pesheva, MD | |
|
850 S Atlantic Blvd Ste 301, Monterey Park, CA 91754-6710 | |
| (626) 289-7699 | |
| Not Available |
| Full Name | Maria Petrova Pesheva |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Experience | 32 Years |
| Location | 850 S Atlantic Blvd Ste 301, Monterey Park, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073557351 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | A88707 (California) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Paul T Urrea M D M P H Inc | 9638130735 | 5 |
News Archive
In January 2012, the OAC and Obesity PPM will launch a long-term online educational initiative to increase understanding of the complexity of obesity and its many causes. The disease of obesity impacts individuals physically, emotionally, economically and socially. This initiative will look at various factors, both controllable and uncontrollable, impacting individuals affected by obesity.
Getting more greens into your diet could cut your risk of heart disease and stroke by as much as 40 per cent, according to new research from Edith Cowan University.
Bayer has announced that a Phase III trial evaluating its oncology compound Stivarga® (regorafenib) tablets for the treatment of patients with unresectable hepatocellular carcinoma (HCC) has met its primary endpoint of a statistically significant improvement in overall survival. The study, called RESORCE, evaluated the efficacy and safety of regorafenib in patients with HCC whose disease has progressed after treatment with sorafenib. The safety and tolerability were generally consistent with the known profile of regorafenib. Detailed efficacy and safety analyses from this study are expected to be presented at an upcoming scientific congress.
Patients diagnosed with high blood pressure are given better control of their condition from a physician-pharmacist collaborative intervention than physician management alone, according to new research.
› Verified 1 days ago
| Entity Name | Southern California Permanente Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770515280 PECOS PAC ID: 6002729175 Enrollment ID: O20031110000678 |
News Archive
In January 2012, the OAC and Obesity PPM will launch a long-term online educational initiative to increase understanding of the complexity of obesity and its many causes. The disease of obesity impacts individuals physically, emotionally, economically and socially. This initiative will look at various factors, both controllable and uncontrollable, impacting individuals affected by obesity.
Getting more greens into your diet could cut your risk of heart disease and stroke by as much as 40 per cent, according to new research from Edith Cowan University.
Bayer has announced that a Phase III trial evaluating its oncology compound Stivarga® (regorafenib) tablets for the treatment of patients with unresectable hepatocellular carcinoma (HCC) has met its primary endpoint of a statistically significant improvement in overall survival. The study, called RESORCE, evaluated the efficacy and safety of regorafenib in patients with HCC whose disease has progressed after treatment with sorafenib. The safety and tolerability were generally consistent with the known profile of regorafenib. Detailed efficacy and safety analyses from this study are expected to be presented at an upcoming scientific congress.
Patients diagnosed with high blood pressure are given better control of their condition from a physician-pharmacist collaborative intervention than physician management alone, according to new research.
› Verified 1 days ago
| Entity Name | Paul T Urrea M D M P H Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619074838 PECOS PAC ID: 9638130735 Enrollment ID: O20041021001057 |
News Archive
In January 2012, the OAC and Obesity PPM will launch a long-term online educational initiative to increase understanding of the complexity of obesity and its many causes. The disease of obesity impacts individuals physically, emotionally, economically and socially. This initiative will look at various factors, both controllable and uncontrollable, impacting individuals affected by obesity.
Getting more greens into your diet could cut your risk of heart disease and stroke by as much as 40 per cent, according to new research from Edith Cowan University.
Bayer has announced that a Phase III trial evaluating its oncology compound Stivarga® (regorafenib) tablets for the treatment of patients with unresectable hepatocellular carcinoma (HCC) has met its primary endpoint of a statistically significant improvement in overall survival. The study, called RESORCE, evaluated the efficacy and safety of regorafenib in patients with HCC whose disease has progressed after treatment with sorafenib. The safety and tolerability were generally consistent with the known profile of regorafenib. Detailed efficacy and safety analyses from this study are expected to be presented at an upcoming scientific congress.
Patients diagnosed with high blood pressure are given better control of their condition from a physician-pharmacist collaborative intervention than physician management alone, according to new research.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Maria Petrova Pesheva, MD 850 S Atlantic Blvd Ste 301, Monterey Park, CA 91754-6710 Ph: (626) 289-7699 | Maria Petrova Pesheva, MD 850 S Atlantic Blvd Ste 301, Monterey Park, CA 91754-6710 Ph: (626) 289-7699 |
News Archive
In January 2012, the OAC and Obesity PPM will launch a long-term online educational initiative to increase understanding of the complexity of obesity and its many causes. The disease of obesity impacts individuals physically, emotionally, economically and socially. This initiative will look at various factors, both controllable and uncontrollable, impacting individuals affected by obesity.
Getting more greens into your diet could cut your risk of heart disease and stroke by as much as 40 per cent, according to new research from Edith Cowan University.
Bayer has announced that a Phase III trial evaluating its oncology compound Stivarga® (regorafenib) tablets for the treatment of patients with unresectable hepatocellular carcinoma (HCC) has met its primary endpoint of a statistically significant improvement in overall survival. The study, called RESORCE, evaluated the efficacy and safety of regorafenib in patients with HCC whose disease has progressed after treatment with sorafenib. The safety and tolerability were generally consistent with the known profile of regorafenib. Detailed efficacy and safety analyses from this study are expected to be presented at an upcoming scientific congress.
Patients diagnosed with high blood pressure are given better control of their condition from a physician-pharmacist collaborative intervention than physician management alone, according to new research.
› Verified 1 days ago
Dr. Cheraphat Lopansri, MD Ophthalmology Medicare: Medicare Enrolled Practice Location: 223 N Garfield Ave., #306, Monterey Park, CA 91754 Phone: 626-573-5005 Fax: 626-573-8650 | |
Dr. Tin-cheu Wong, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 420 N Garfield Ave Ste 208, Monterey Park, CA 91754 Phone: 626-572-3937 Fax: 626-571-8819 | |
Bach Lan Linda Vu, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 511 E Garvey Ave, Suite 201, Monterey Park, CA 91755 Phone: 626-382-2020 Fax: 626-382-2015 | |
Calvin Eng, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 850 S Atlantic Blvd, Suite 301, Monterey Park, CA 91754 Phone: 626-289-8260 Fax: 626-289-4242 | |
Jennifer Shin-hue Huang, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 850 S Atlantic Blvd Ste 301, Monterey Park, CA 91754 Phone: 626-289-8260 Fax: 626-289-4242 | |
Joseph T Fan, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 500 N Garfield Ave Ste 209, Monterey Park, CA 91754 Phone: 626-288-2265 Fax: 626-288-3761 |